Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros

Banco de datos
Tipo de estudio
Tipo del documento
Intervalo de año de publicación
1.
Nat Med ; 12(2): 235-9, 2006 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-16462802

RESUMEN

The angiopoietins Ang-1 and Ang-2 have been identified as ligands of the receptor tyrosine kinase Tie-2 (refs. 1,2). Paracrine Ang-1-mediated activation of Tie-2 acts as a regulator of vessel maturation and vascular quiescence. In turn, the antagonistic ligand Ang-2 acts by an autocrine mechanism and is stored in endothelial Weibel-Palade bodies from where it can be rapidly released upon stimulation. The rapid release of Ang-2 implies functions of the angiopoietin-Tie system beyond its established role during vascular morphogenesis as a regulator of rapid vascular responses. Here we show that mice deficient in Ang-2 (encoded by the gene Angpt2) cannot elicit an inflammatory response in thioglycollate-induced or Staphylococcus aureus-induced peritonitis, or in the dorsal skinfold chamber model. Recombinant Ang-2 restores the inflammation defect in Angpt2(-/-) mice. Intravital microscopy showed normal TNF-alpha-induced leukocyte rolling in the vasculature of Angpt2(-/-)mice, but rolling cells did not firmly adhere to activated endothelium. Cellular experiments showed that Ang-2 promotes adhesion by sensitizing endothelial cells toward TNF-alpha and modulating TNF-alpha-induced expression of endothelial cell adhesion molecules. Together, these findings identify Ang-2 as an autocrine regulator of endothelial cell inflammatory responses. Ang-2 thereby acts as a switch of vascular responsiveness exerting a permissive role for the activities of proinflammatory cytokines.


Asunto(s)
Angiopoyetina 2/fisiología , Inflamación/etiología , Factor de Necrosis Tumoral alfa/fisiología , Angiopoyetina 1/fisiología , Angiopoyetina 2/deficiencia , Angiopoyetina 2/genética , Animales , Citocinas/fisiología , Endotelio Vascular/patología , Endotelio Vascular/fisiopatología , Humanos , Inflamación/patología , Inflamación/fisiopatología , Mediadores de Inflamación/fisiología , Ratones , Ratones Noqueados , Modelos Biológicos , Neovascularización Patológica , Transducción de Señal
2.
J Cataract Refract Surg ; 34(3): 497-504, 2008 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-18299078

RESUMEN

PURPOSE: To determine the effect of the modification of intraocular lens (IOL) surface properties on the adhesion of Staphylococcus epidermidis caused by fibronectin (FN) as the predominant proadhesive glycoprotein of the eye's initial foreign body reaction. SETTING: University of Saarland, Homburg/Saar, Germany. METHODS: Eleven IOL types were tested. The IOLs were of poly(methyl methacrylate), acrylate, or silicone. Some were surface modified with heparin or polysaccharide coating. The IOLs, unadsorbed or preadsorbed with fibronectin (FN), were incubated with [(3)H]-thymidine-labeled S epidermidis Rp62a, and the amount of adherent microorganisms was determined. RESULTS: Attachment of S epidermidis adhesion to various types of IOLs, both unadsorbed and FN precoated, varied significantly. The attachment to highly adhesive IOLs was almost 4-fold greater than that to low-adhesive IOLs. Attachment to FN precoated IOLs was generally enhanced compared with attachment to unadsorbed IOLs. Heparin surface modification resulted in no or a modest reduction in bacterial adhesion compared with unmodified IOLs. Bacterial adhesion was highly statistically significantly less on IOLs with polysaccharide surface modification. CONCLUSIONS: There was significant variability in S epidermidis adhesion to IOLs as a function of design, material, surface modification, and FN preadsorption. Application of the findings may foster new developments to further reduce the major complication in cataract surgery, infective endophthalmitis.


Asunto(s)
Adhesión Bacteriana/fisiología , Materiales Biocompatibles Revestidos , Fibronectinas/farmacología , Heparina , Lentes Intraoculares/microbiología , Polisacáridos , Staphylococcus epidermidis/fisiología , Acrilatos , Adhesión Bacteriana/efectos de los fármacos , Polimetil Metacrilato , Diseño de Prótesis , Elastómeros de Silicona
3.
FASEB J ; 20(14): 2621-3, 2006 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-17077291

RESUMEN

The extracellular adherence protein (Eap), a broad-spectrum adhesin secreted by Staphylococcus aureus, was previously shown to curb acute inflammatory responses, presumably through its binding to endothelial cell (EC) ICAM-1. Examining the effect of Eap on endothelial function in more detail, we here show that, in addition, Eap functions as a potent angiostatic agent. Concomitant treatment of EC with purified Eap resulted in the complete blockage of the mitogenic and sprouting responses elicited by vascular endothelial growth factor (VEGF)165 or basic fibroblast growth factor (bFGF). Moreover, the induction of tissue factor and decay-accelerating factor were repressed by Eap, as determined by qRT-polymerase chain reaction (qRT-PCR), with a corresponding reduction in Egr-1 protein up-regulation seen. This angiostatic activity was accompanied by a corresponding inhibition in ERK1/2 phosphorylation, while activation of p38 was not affected. Inhibition occurred downstream of tyrosine kinase receptor activation, as comparable effects were seen on TPA-induced ERK1/2 phosphorylation. Similar to previously described angiostatic agents like angiopoietin-1 or the 16-kDa prolactin fragment, Eap blockage of the Ras/Raf/MEK/ERK cascade was localized by pull-down assay at the level of Ras activation. Eap's combined anti-inflammatory and antiangiogenic properties render this bacterial protein not only an important virulence factor during S. aureus infection but open new perspectives for therapeutic applications in pathological neovascularization.


Asunto(s)
Proteínas Bacterianas/farmacología , Células Endoteliales/efectos de los fármacos , Células Endoteliales/metabolismo , Neovascularización Fisiológica/efectos de los fármacos , Proteínas de Unión al ARN/farmacología , Proteínas ras/antagonistas & inhibidores , Proteínas Bacterianas/metabolismo , Proliferación Celular/efectos de los fármacos , Células Cultivadas , Factores de Crecimiento de Fibroblastos/metabolismo , Humanos , Quinasas de Proteína Quinasa Activadas por Mitógenos/metabolismo , Neovascularización Fisiológica/fisiología , Fosfolipasa C gamma/metabolismo , Proteínas Proto-Oncogénicas c-raf/metabolismo , Proteínas de Unión al ARN/metabolismo , Transducción de Señal , Factor A de Crecimiento Endotelial Vascular/metabolismo , Proteínas ras/metabolismo
4.
Blood ; 107(7): 2720-7, 2006 Apr 01.
Artículo en Inglés | MEDLINE | ID: mdl-16317095

RESUMEN

Staphylococcus aureus is a major human pathogen interfering with host-cell functions. Impaired wound healing is often observed in S aureus-infected wounds, yet, the underlying mechanisms are poorly defined. Here, we identify the extracellular adherence protein (Eap) of S aureus to be responsible for impaired wound healing. In a mouse wound-healing model wound closure was inhibited in the presence of wild-type S aureus and this effect was reversible when the wounds were incubated with an isogenic Eap-deficient strain. Isolated Eap also delayed wound closure. In the presence of Eap, recruitment of inflammatory cells to the wound site as well as neovascularization of the wound were prevented. In vitro, Eap significantly reduced intercellular adhesion molecule 1 (ICAM-1)-dependent leukocyte-endothelial interactions and diminished the consequent activation of the proinflammatory transcription factor nuclear factor kappaB (NFkappaB) in leukocytes associated with a decrease in expression of tissue factor. Moreover, Eap blocked alphav-integrin-mediated endothelial-cell migration and capillary tube formation, and neovascularization in matrigels in vivo. Collectively, the potent anti-inflammatory and antiangiogenic properties of Eap provide an underlying mechanism that may explain the impaired wound healing in S aureus-infected wounds. Eap may also serve as a lead compound for new anti-inflammatory and antiangiogenic therapies in several pathologies.


Asunto(s)
Proteínas Bacterianas/farmacología , Endotelio Vascular/fisiología , Neovascularización Fisiológica/efectos de los fármacos , Proteínas de Unión al ARN/farmacología , Staphylococcus aureus/patogenicidad , Cicatrización de Heridas/efectos de los fármacos , Heridas y Lesiones/fisiopatología , Animales , Proteínas Bacterianas/genética , Adhesión Celular/efectos de los fármacos , Adhesión Celular/fisiología , Línea Celular , Movimiento Celular/efectos de los fármacos , Secuencia de Consenso , Modelos Animales de Enfermedad , Endotelio Vascular/efectos de los fármacos , Endotelio Vascular/microbiología , Eliminación de Gen , Humanos , Molécula 1 de Adhesión Intercelular/fisiología , Leucocitos/efectos de los fármacos , Leucocitos/microbiología , Leucocitos/fisiología , Ratones , FN-kappa B/genética , FN-kappa B/metabolismo , Proteínas de Unión al ARN/genética , Staphylococcus aureus/genética , Venas Umbilicales , Heridas y Lesiones/microbiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA